PCVX · Vaxcyte, Inc. · Webcasts, Transcripts & Audio
$60.16
+1.64 (+2.80%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q4 2025 earnings call transcript
Market Cap
$9.26B
Shares
158.30M
Volume · Nov 19
172.87K
Avg daily vol (3M)
2.16M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Vaxcyte, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Vaxcyte, Inc. (PCVX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-18
Vaxcyte, Inc. (PCVX) November 18, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-11-10
Vaxcyte, Inc. (PCVX) November 10, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-10-05
Vaxcyte, Inc. (PCVX) Q3 2026 Earnings Call
Diluted EPS
$-1.99
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-08
Vaxcyte, Inc. (PCVX) September 8, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Annual General Meeting
Investor event
2026-06-15
Vaxcyte, Inc. (PCVX) June 15, 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-06
Vaxcyte, Inc. (PCVX) Q1 2026 Earnings Call
Diluted EPS
$-2.30
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Vaxcyte, Inc. (PCVX) Q4 2025 Earnings Call Transcript
Confident tone
VAX-31 Adult Phase III (Opus) Program
Infant Program (VAX-31 / VAX-24)
Competitive Positioning vs. PCV20 and PCV21
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Vaxcyte, Inc. (PCVX) Q3 2025 Earnings Call
Diluted EPS
$-1.56
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Vaxcyte, Inc. (PCVX) Q2 2025 Earnings Call
Diluted EPS
$-1.22
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Vaxcyte, Inc. (PCVX) Q1 2025 Earnings Call
Diluted EPS
$-1.04
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-31
Vaxcyte, Inc. (PCVX) Q4 2024 Earnings Call Transcript
Confident tone
Infant pipeline and VAX-24/VAX-31 infant programs
VAX-31 clinical progress and Phase 3 advancement
ACIP recommendations and preferred status
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-05
Vaxcyte, Inc. (PCVX) Q3 2024 Earnings Call
Diluted EPS
$-0.83
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
Vaxcyte, Inc. (PCVX) Q1 2024 Earnings Call
Diluted EPS
$-0.85
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Vaxcyte, Inc. (PCVX) Q4 2023 Earnings Call Transcript
Confident tone
VAX-24 adult program
VAX-31 adult program
Regulatory and competitive landscape (V116, ACIP)
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q4
2023-04-17
Vaxcyte, Inc. (PCVX) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q4
2022-02-28
Vaxcyte, Inc. (PCVX) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q4
2021-03-29
Vaxcyte, Inc. (PCVX) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–17 of 17 webcasts
Key facts
CIK
1649094
CUSIP
92243G108
13F (30d)
372 filings
338 filers
Visit website
Investor relations